In 2017, Wang et al. used an in vivo HFD-induced NAFLD SD rat model and an in vitro FFA-exposed BRL3A rat cell line to study the involvement of NEAT1 in the development and progression of NAFLD. This evidence concerns the gene NEAT1 and metabolic dysfunction-associated steatotic liver disease.